A photo finish at a horse race with both horses crossing the finish line
Research

China approved the first solid tumor CAR-T. Will the US follow?

While satri-cel may soon broaden its reach to more Chinese patients, the game-changing therapy is unlikely to hit the American market anytime soon.
Darren Incorvaia Jun 30, 2026 10:00am
Worker bees in hive seen through honeycomb

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am
delay

Praxis faces FDA delay, analysts point finger at agency layoffs

Jun 30, 2026 4:13am
Goal disorientation and lack of vision

Vistagen fails another phase 3 anxiety trial, spies path forward

Jun 30, 2026 9:48am
FDA

FDA gene therapy regulator steps down from leadership role

Jun 30, 2026 10:36am
iStock-654068644png

Abivax stock rebounds on colitis prospect safety data

Jun 30, 2026 10:27am
More News

Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE

Jun 30, 2026 8:00am
Fierce Pharma

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am

BioCryst ends internal programs in pivot to partnerships

Jun 29, 2026 10:30am

Evommune’s phase 2b flops, ending challenge to Novartis in hives

Jun 29, 2026 10:00am